Overall rank by patents
#4,462
Across all tracked assignees
USPTO PatentsView assignee record - 79 granted patents across 20 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
ECA holds 79 US patents across 20 technology areas, rank #4,462 of 50,000 tracked assignees.
ECA Medical Instruments has been granted 79 US utility patents between 2015 and 2025, placing ECA Medical Instruments at rank #4,462 across all assignees tracked by PlainPatent. This portfolio spans 20 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.2 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, ECA Medical Instruments is one of the more focused assignees in the PatentsView dataset. By volume, ECA sits between Cadila Healthcare Ltd. (79 patents, rank #4,458) and Fallbrook Intellectual Property Company Llc (79 patents, rank #4,466) - the closest US assignees by grant volume. The composite Innovation Score of 43.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 33 grants, compared with 46 in the 2015–2019 window, a -28% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. ECA Medical Instruments's 12.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 20 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark ECA Medical Instruments against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Cadila Healthcare Ltd.
79 patents
Corning Precision Materials Co., Ltd.
79 patents
CreateMe Technologies Inc.
79 patents
EARLY MORNING LLC
79 patents
ELAN MICROELECTRONICS CORPORATION
79 patents
Enel X North America, Inc.
79 patents
Exelis Inc.
79 patents
Fallbrook Intellectual Property Company LLC
79 patents
ECA Medical Instruments
79 patents
What this shows ECA holds 79 patents at rank #4,462, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,462 in granted patent volume.
Other assignees with the most granted patents in ECA's primary technology class.
ECA's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
44 Top 28% higher than 72% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 7.6% |
| 2016 | 10 | 12.7% |
| 2017 | 9 | 11.4% |
| 2018 | 13 | 16.5% |
| 2019 | 8 | 10.1% |
| 2020 | 4 | 5.1% |
| 2021 | 9 | 11.4% |
| 2022 | 7 | 8.9% |
| 2023 | 8 | 10.1% |
| 2024 | 2 | 2.5% |
| 2025 | 3 | 3.8% |
Top 15 of 20 technology areas
Overall rank by patents
#4,462
Across all tracked assignees
43.6 out of 100
How to use this portfolio
ECA's 79 grants land it in the top 28% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.